Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE
- PMID: 35678066
- PMCID: PMC9544782
- DOI: 10.1111/1756-185X.14357
Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE
Abstract
Objective: Psoriatic arthritis (PsA), a chronic inflammatory arthropathy, is often underdiagnosed in Middle Eastern countries, substantially impacting the treatment of affected individuals. This article aims to highlight current unmet clinical needs and provide consensus recommendations for region-specific evaluation methods and nonpharmacological therapies in the United Arab Emirates (UAE).
Method: An extensive literature review was conducted, focusing especially on global and regional guidelines for the evaluation and treatment of PsA. These form the basis of the consensus statements formulated. Additionally, an expert panel of key opinion leaders from the UAE reviewed these guidelines and available literature at an advisory board meeting to identify unmet needs, bridge clinical gaps in the UAE, and develop consensus statements for the evaluation and treatment of PsA.
Result: The consensus statements were developed based on overarching principles for the management of PsA, evaluation of patients with PsA, and nonpharmacological approaches for the management of PsA. The overarching principles included adopting a targeted, multidisciplinary approach, along with collaboration between rheumatologists and dermatologists in cases of clinically significant skin involvement. The panel also highlighted the value of composite disease severity measures for characterizing clinical manifestations of PsA. In terms of nonpharmacological management approaches, lifestyle modification (comprising dietary change, exercise, and cessation of smoking) and psychotherapy were recommended.
Conclusion: The consensus statements will aid healthcare professionals in clinical decision-making in the context of PsA.
Keywords: assessment tools; guidelines; nonpharmacological approach; overarching principles; psoriatic arthritis; severity.
© 2022 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors have no conflict of interest related to this work. The consensus guidelines were funded by the Emirates Society for Rheumatology, a nonprofit organization.
References
-
- Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of Spondyloarthritis: a systematic review and meta‐regression analysis. Arthritis Care Res (Hoboken). 2016;68(9):1320‐1331. - PubMed
-
- Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354‐1358. - PubMed
-
- Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573. - PubMed
-
- Al‐Awadhi AM, Olusi SO, Moussa M, et al. Musculoskeletal pain, disability and health‐seeking behavior in adult Kuwaitis using a validated Arabic version of the WHO‐ILAR COPCORD Core questionnaire. Clin Exp Rheumatol. 2004;22(2):177‐183. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
